Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):967-8. doi: 10.1111/j.1468-3083.2008.03074.x. Epub 2009 Jan 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use*
  • Infliximab
  • Lymphoma, T-Cell, Cutaneous / chemically induced*
  • Lymphoma, T-Cell, Cutaneous / diagnosis
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Risk Factors
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / diagnosis
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept